Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 21% ± 5% | |
keratinocyte | 3 studies | 20% ± 5% |
Insufficient scRNA-seq data for expression of GJB3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 39% | 2236.86 | 557 / 1445 | 93% | 92.94 | 171 / 183 |
bladder | 29% | 208.76 | 6 / 21 | 86% | 65.52 | 433 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 84.16 | 1 / 1 |
intestine | 9% | 91.24 | 91 / 966 | 90% | 46.60 | 475 / 527 |
tonsil | 0% | 0 | 0 / 0 | 98% | 162.25 | 44 / 45 |
pancreas | 0% | 0 | 0 / 328 | 88% | 66.93 | 157 / 178 |
stomach | 7% | 45.57 | 26 / 359 | 78% | 33.09 | 222 / 286 |
skin | 72% | 8230.66 | 1301 / 1809 | 8% | 3.44 | 40 / 472 |
uterus | 1% | 27.22 | 2 / 170 | 77% | 108.40 | 352 / 459 |
lung | 1% | 5.33 | 5 / 578 | 66% | 41.60 | 767 / 1155 |
thymus | 0% | 0 | 0 / 653 | 65% | 22.99 | 394 / 605 |
ovary | 0% | 0 | 0 / 180 | 60% | 14.49 | 257 / 430 |
prostate | 32% | 278.24 | 78 / 245 | 9% | 1.40 | 46 / 502 |
breast | 0% | 0 | 0 / 459 | 13% | 4.79 | 150 / 1118 |
liver | 1% | 7.12 | 3 / 226 | 10% | 2.90 | 39 / 406 |
kidney | 1% | 6.56 | 1 / 89 | 6% | 1.42 | 50 / 901 |
brain | 0% | 1.67 | 9 / 2642 | 0% | 0.03 | 2 / 705 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.07 | 1 / 230 |
adipose | 0% | 6.02 | 3 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.77 | 1 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.60 | 1 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 4.44 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0071300 | Biological process | cellular response to retinoic acid |
GO_0007267 | Biological process | cell-cell signaling |
GO_0055085 | Biological process | transmembrane transport |
GO_0007283 | Biological process | spermatogenesis |
GO_0043588 | Biological process | skin development |
GO_0001701 | Biological process | in utero embryonic development |
GO_0001890 | Biological process | placenta development |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0030054 | Cellular component | cell junction |
GO_0005922 | Cellular component | connexin complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005921 | Cellular component | gap junction |
GO_0005243 | Molecular function | gap junction channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GJB3 |
Protein name | Gap junction beta-3 protein (Connexin-31) (Cx31) |
Synonyms | CX31 |
Description | FUNCTION: One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. |
Accessions | ENST00000373362.3 ENST00000373366.3 O75712 |